methyprylon   Click here for help

GtoPdb Ligand ID: 7238

Synonyms: Noludar®
Approved drug
methyprylon is an approved drug
Compound class: Synthetic organic
Comment: Methyprylon is a piperidinedione derivative sedative. It is not available in the UK or US.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 2
Topological polar surface area 49.66
Molecular weight 183.13
XLogP 1.57
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCC1(CC)C(=NCC(C1=O)C)O
Isomeric SMILES CCC1(CC)C(=NCC(C1=O)C)O
InChI InChI=1S/C10H17NO2/c1-4-10(5-2)8(12)7(3)6-11-9(10)13/h7H,4-6H2,1-3H3,(H,11,13)
InChI Key SIDLZWOQUZRBRU-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
This drug was used for treating insomnia. However, there is no information regarding approval for clinical use of this drug on the US FDA website. Other national approval agencies may have granted marketing authorisation.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
Methyprylon binds to a distinct site within Cl ionophore of GABAA ion channels. The drug increases inhibitory GABAergic tone and causes neuro-inhibition.
Due to the complex and varied nature of the precise subunit composition of GABAA receptors, and a paucity of affinity data with definitive molecular details, we have not tagged a primary target for this drug.